Three-Child Policy

Fuhai Launches Global First Infant Formula Ingredient Traceability System

China Feihui Subsidiary Purchases Financial Products from CITIC Bank

China Feihui Repurchased 8.53 Million Shares for HKD 35.77 Million

Mengniu Dairy repurchased 200,000 shares for HKD 3,022,700

China Feihui Limited repurchased 2.95 million shares

Fuyeh Announces Major Repurchase and Dividend Plan Alongside its 2025 H1 Financial Report

Mengniu Dairy Repurchased 200,000 Shares for HKD 2.9675 Million

Chinese Feihe Repurchased More Than 5.65 Million Shares on HKEX

Tsai Yan Ming Increased Holdings in China 旺旺 Stock

Mengniu Dairy repurchased 200,000 shares

China Feihui Co., Ltd Repurchased 1,969,000 Ordinary Shares

China Feihui Limited Discloses Repurchase Plan and Submits Application

Fuhai and JD Collaborate on Launching Next-Generation Fresh Nutrient Infant Formula

China Feihui repurchased 7 million shares

Tsai Yan-ming Increased Holdings of China Mengniu 208,000 Shares

Mengniu Dairy Repurchased 200,000 Shares for HKD 2.918 Million

China Feihui Limited repurchased 3 million shares

Mengniu Dairy Repurchased 200,000 Shares for HKD 2.944 Million

China Feihui Limited repurchased 4 million shares

Yili and Mengniu See Growing Performance Gap

GP LOGISTICS

MODERN LIVING

CENTRALCHINA MT

THELLOY DEV

TRANSTECH

DTXS SILK ROAD

CAPITAL VC

SHENYANG PUBLIC

CPM GROUP

ZIJING INTL FIN

601998

00998

06186

China Feihe announced that on December 18th, its wholly-owned subsidiary Heilongjiang Feihe subscribed to a financial product issued by CITIC BANK with idle funds amounting to 300 million RMB. To date, the total principal amount of wealth management and structured deposit financial products subscribed by the Group from CITIC BANK that have not yet matured is 2.5 billion RMB

AASTOCKS

CNCB

CITIC BANK

CHINA FEIHE

CHINA FEIHE spent 300 million RMB to subscribe to Xinhang financial products

China Feihe Ltd. has disclosed to the Hong Kong Stock Exchange the repurchase of 8.53 million shares for HKD 35.77 million, with an average price of HKD 4.194 per share.

Reuters

China Feihe Files Disclosure to HKEX on Repurchase of 8.53 Million Shares for HKD 35.77 Million

02943

00286

Aidigong Maternal & Child Health Limited announced the resignation of Wong Wing Cheung as company secretary and authorised representative, effective December 19, 2025. Tam Mei Chu has been appointed as the new company secretary and authorised representative from the same date.

YUZHOU GROUP

AIDIGONG

Aidigong Maternal & Child Health Appoints Tam Mei Chu as Company Secretary

China Feihe Ltd. announced the repurchase of 3,046,000 shares at an average price of HKD 4.0469 per share, totaling HKD 12,326,900, as disclosed in a filing with the Hong Kong Stock Exchange.

China Feihe Files HKEX Disclosure on Repurchase of 3,046,000 Shares at HKD 12,326,900

China Feihe Ltd. repurchased 2.95 million shares for HK$11.87 million, filing a disclosure with HKEX. The shares are held as treasury shares.

China Feihe Repurchases 2.95 Million Shares for HK$11.87 Million, Files Disclosure to HKEX

China Feihe Ltd :UNIT SUBSCRIBES FOR CITIC BANK PRODUCT FOR RMB700 MILLION

China Feihe Says Unit Subscribes For Citic Bank Product For RMB700 Million

China Feihe Limited's subsidiary, Feihe HLJ Sales, has invested RMB700 million in a CITIC Bank financial product to boost capital gains. This strategic investment aims to enhance returns with minimal risk, without affecting the company's working capital or operations. The investment aligns with the company's objectives of maintaining capital safety and liquidity. The latest analyst rating for China Feihe Limited's stock is a Hold with a HK$4.30 price target.

Tip Ranks

China Feihe Limited Invests in CITIC Bank Financial Product to Boost Capital Gains

China Feihe announced that on December 16th (today), its wholly-owned subsidiary Heilongjiang Feihe Sales subscribed to a wealth management financial product issued by CITIC BANK with an amount of RMB 700 million using its idle funds. The maturity date is December 16th of next year, with an expected annual yield of 2.4% to 2.9%

CHINA FEIHE's subsidiary subscribes to 700 million RMB financial products

Aidigong Maternal & Child Health Limited has filed an updated list of directors with the Hong Kong Stock Exchange. The board includes Executive Directors Mr. Huang Wenhua, Mr. Lin Jiang, Mr. Li Runping, and Ms. Meng Lijia, and Independent Non-Executive Directors Mr. Wang Bin, Mr. Chu Pui Ki Dickson, and Mr. Ma Siu Kit. The filing details their roles in various committees.

Aidigong Maternal & Child Health Files Director List with HKEX

Aidigong Maternal & Child Health Limited has appointed Mr. Ma Siu Kit as an independent non-executive director and a member of the Audit Committee, effective December 12, 2025. The board now includes four executive directors and three independent non-executive directors.

Aidigong Appoints Ma Siu Kit as Independent Non-Executive Director

China Feihe Ltd. disclosed repurchasing 5.66 million shares for HKD 23.18 million, averaging HKD 4.0988 per share, to be held as treasury shares. This was filed with HKEX.

China Feihe Files HKEX Disclosure on Repurchase of 5.66 Million Shares for HKD 23.18 Million

China Feihe Ltd. has repurchased 1,969,000 ordinary shares for HKD 8,033,520, with an average price of HKD 4.08 per share, as disclosed in a filing with the Hong Kong Stock Exchange. The shares will be held as treasury shares.

China Feihe Repurchases 1,969,000 Shares for HKD 8 Million in HKEX Disclosure

01628

Yuzhou Group Logs 581 Million Yuan in November Sales

marketscreener

Yuzhou Group Logs 581 Million Yuan in November Sales

Yuzhou Group reported unaudited sales of RMB581 million for November 2025, with a GFA of 51,252 sqm and an average price of RMB11,339/sqm. Accumulated sales for the first eleven months reached RMB6,196 million. Figures are preliminary and may change. Investors should exercise caution.

Yuzhou Group Reports RMB581 Million Sales for November 2025

China Feihe Ltd. repurchased 8,007,000 shares for HKD 32.93 million, filing a disclosure with HKEX. The shares are held as treasury shares at an average price of HKD 4.1124 per share.

China Feihe Files HKEX Disclosure After Repurchasing 8,007,000 Shares for HKD 32.93 Million

$GOODBABY INTL(01086.HK) that is insane！

GOODBABY INTL

$CHINA FEIHE(06186.HK) feels like Hong Kong tech stocks are stagnating, so I switched to consumer stocks. I bought Feihe because the chart looked tight, but didn't expect a policy announcement today.